Yorvipath Interactions
There are 33 drugs known to interact with Yorvipath (palopegteriparatide), along with 2 disease interactions. Of the total drug interactions, 33 are moderate.
- View all 33 medications that may interact with Yorvipath
- View Yorvipath disease interactions (2)
Most frequently checked interactions
View interaction reports for Yorvipath (palopegteriparatide) and the medicines listed below.
- Abilify (aripiprazole)
- acetaminophen
- Acidophilus Probiotic Blend (lactobacillus acidophilus)
- Airborne Gummies (multivitamin with minerals)
- Allegra Allergy (fexofenadine)
- amlodipine
- armodafinil
- ascorbic acid/collagen
- Aspercreme Maximum Strength Lidocaine Patch (lidocaine topical)
- Aspir 81 (aspirin)
- atenolol
- atorvastatin
- azelastine nasal
- bacillus coagulans / inulin
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Bactroban (mupirocin topical)
- Bariatric Multivitamins with 22.5 mg Iron (multivitamin with minerals)
- Bentyl (dicyclomine)
- biotin
- Breo Ellipta (fluticasone / vilanterol)
- calcium citrate
- chondroitin / glucosamine
- clobetasol topical
- clotrimazole topical
- colchicine
- Cutivate (fluticasone topical)
- desonide topical
- dicyclomine
- docusate
- domperidone
Yorvipath disease interactions
There are 2 disease interactions with Yorvipath (palopegteriparatide) which include:
Report options
QR code containing a link to this page
More about Yorvipath (palopegteriparatide)
- Yorvipath consumer information
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: parathyroid hormone and analogs
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
